Quick Search
Perinatal outcomes of 91 cases of non-immune hydrops fetalis
Emre Erdoğdu1, Resul Arısoy2, Lütfiye Uygur3, Selim Sancak4, Furkan Kayabaşoğlu1, Sevcan Arzu Arınkan5, Oya Pekin3, Murat Muhcu61Department of Perinatology, Alle Health Clinic, İstanbul, Türkiye2Department of Perinatology, Ataşehir Memorial Hospital, İstanbul, Türkiye
3Division of Perinatology, Department of Obstetrics and Gynecology, University of Health Sciences, Türkiye. Zeynep Kamil Maternity and Children’s Training and Research Hospital, İstanbul, Türkiye
4Division of Neonatology, Department of Pediatrics, University of Health Sciences, Türkiye. Zeynep Kamil Maternity and Children’s Training and Research Hospital, İstanbul, Türkiye
5Department of Obstetrics and Gynecology, Haydarpaşa Training and Research Hospital, İstanbul, Türkiye
6Department of Perinatology, Ümraniye Training and Research Hospital, İstanbul, Türkiye
INTRODUCTION: We aimed to investigate the proportion of etiologically identified non-immune hydrops fetalis (NIHF) cases and perinatal outcomes of all the cases that were diagnosed and managed in a single tertiary perinatal center over a 7-year period.
METHODS: Perinatal outcomes, background disorders, and clinical details of the patient and the surviving fetus were retrospectively analyzed.
RESULTS: The etiology was identified prenatally in 60 (65.9%) out of 91 cases. Cystic hygromas and cardiac abnormalities were the most common identifiable causes. Of 91 cases, 48 (52.7%) elected to terminate their pregnancy. Among the 43 patients who elected to continue with their pregnancy, 12 (27.9%) resulted in intrauterine fetal death and 31 (72.1%) survived to birth. The survival rate at discharge was 23.2%.
DISCUSSION AND CONCLUSION: NIHF is a complex problem associated with high mortality. Many patients elect the termination of their pregnancy, and the survival rate is 23.2% in cases who elect to continue with their pregnancy.
Manuscript Language: English
